30 January 2026
-
Why the Biologics Patent Cliff Is Failing to Cut Drug Costs?
Between 2025 and 2029, there is going to be a profound impact on the Pharmaceutical industry, catalysed by the Loss of Exclusivity. The loss of exclusivity signifies the expiration of the patents of biologics, causing a systemwide erosion of the market exclusivity held by several major pharmaceutical companies, resulting in a revenue contraction for these…